Alaunos Therapeutics, Inc. (TCRT): Cash & Equivalents
$1.39M
As of 2025-12-31
$124.0K
As of 2026-06-30
-67.1%
3-year compound annual growth
-58.7%
5-year compound annual growth
-37.0%
10-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $1.39M | +26.9% | 2026-03-31, Balance as of period end |
| 2024-12-31 | $1.09M | -82.0% | 2026-03-31, Balance as of period end |
| 2023-12-31 | $6.06M | -84.5% | 2025-03-31, Balance as of period end |
| 2022-12-31 | $39.06M | -48.6% | 2024-04-01, Balance as of period end |
| 2021-12-31 | $76.05M | -33.9% | 2023-03-07, Balance as of period end |
| 2020-12-31 | $115.07M | +44.3% | 2022-03-30, Balance as of period end |
| 2019-12-31 | $79.74M | +29.2% | 2021-03-01, Balance as of period end |
| 2018-12-31 | $61.73M | -13.0% | 2020-03-02, Balance as of period end |
| 2017-12-31 | $70.95M | -12.5% | 2020-03-02, Balance as of period end |
| 2016-12-31 | $81.05M | -42.4% | 2019-03-05, Balance as of period end |
| 2015-12-31 | $140.72M | +228.8% | 2018-03-01, Balance as of period end |
| 2014-12-31 | $42.80M | -37.2% | 2017-02-16, Balance as of period end |
| 2013-12-31 | $68.20M | -7.0% | 2016-02-24, Balance as of period end |
| 2012-12-31 | $73.31M | -30.0% | 2015-02-26, Balance as of period end |
| 2011-12-31 | $104.71M | +73.4% | 2014-03-03, Balance as of period end |
| 2010-12-31 | $60.39M | +23.7% | 2014-03-03, Balance as of period end |
| 2009-12-31 | $48.84M | +329.2% | 2013-03-18, Balance as of period end |
| 2008-12-31 | $11.38M | n/a | 2012-02-29, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| Alaunos Therapeutics, Inc. (TCRT) | 2025-12-31 | $1.39M | +26.9% |
| Aditxt, Inc. (ADTX) | 2024-12-31 | $833.0K | +757.9% |
| Genelux Corp (GNLX) | 2025-12-31 | $5.33M | -37.7% |
| PRF Technologies Ltd. (PRFX) | 2025-12-31 | $3.12M | -26.7% |
| Bioadaptives, Inc. (BDPT) | 2025-12-31 | $215.2K | -17.8% |
| Talphera, Inc. (TLPH) | 2025-12-31 | $5.89M | -33.5% |
| Impact Biomedical Inc. (IBO) | 2025-12-31 | $3.0K | -99.8% |
| Lyell Immunopharma, Inc. (LYEL) | 2025-12-31 | $60.18M | -43.0% |
| Neonc Technologies Holdings, Inc. (NTHI) | 2025-12-31 | $58.7K | -9.5% |
Compare TCRT, ADTX, GNLX, PRFX side by side · Screen every company in Pharmaceutical Preparations ↗